765 related articles for article (PubMed ID: 16084554)
1. Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics.
Tian G; Zhang S; Li Y; Bu Z; Liu P; Zhou J; Li C; Shi J; Yu K; Chen H
Virology; 2005 Oct; 341(1):153-62. PubMed ID: 16084554
[TBL] [Abstract][Full Text] [Related]
2. Potency of an inactivated avian influenza vaccine prepared from a non-pathogenic H5N1 reassortant virus generated between isolates from migratory ducks in Asia.
Isoda N; Sakoda Y; Kishida N; Soda K; Sakabe S; Sakamoto R; Imamura T; Sakaguchi M; Sasaki T; Kokumai N; Ohgitani T; Saijo K; Sawata A; Hagiwara J; Lin Z; Kida H
Arch Virol; 2008; 153(9):1685-92. PubMed ID: 18651092
[TBL] [Abstract][Full Text] [Related]
3. Vaccines developed for H5 highly pathogenic avian influenza in China.
Qiao C; Tian G; Jiang Y; Li Y; Shi J; Yu K; Chen H
Ann N Y Acad Sci; 2006 Oct; 1081():182-92. PubMed ID: 17135510
[TBL] [Abstract][Full Text] [Related]
4. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
[TBL] [Abstract][Full Text] [Related]
5. Principles for vaccine protection in chickens and domestic waterfowl against avian influenza: emphasis on Asian H5N1 high pathogenicity avian influenza.
Swayne DE
Ann N Y Acad Sci; 2006 Oct; 1081():174-81. PubMed ID: 17135509
[TBL] [Abstract][Full Text] [Related]
6. The immunogenicity and efficacy against H5N1 challenge of reverse genetics-derived H5N3 influenza vaccine in ducks and chickens.
Webster RG; Webby RJ; Hoffmann E; Rodenberg J; Kumar M; Chu HJ; Seiler P; Krauss S; Songserm T
Virology; 2006 Aug; 351(2):303-11. PubMed ID: 16690097
[TBL] [Abstract][Full Text] [Related]
7. Enhanced protective efficacy of H5 subtype avian influenza DNA vaccine with codon optimized HA gene in a pCAGGS plasmid vector.
Jiang Y; Yu K; Zhang H; Zhang P; Li C; Tian G; Li Y; Wang X; Ge J; Bu Z; Chen H
Antiviral Res; 2007 Sep; 75(3):234-41. PubMed ID: 17451817
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
Jadhao SJ; Lee CW; Sylte M; Suarez DL
Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of inactivated vaccines against H5N1 avian influenza infection in ducks.
Middleton D; Bingham J; Selleck P; Lowther S; Gleeson L; Lehrbach P; Robinson S; Rodenberg J; Kumar M; Andrew M
Virology; 2007 Mar; 359(1):66-71. PubMed ID: 17028058
[TBL] [Abstract][Full Text] [Related]
10. H5N1 influenza marker vaccine for serological differentiation between vaccinated and infected chickens.
Li C; Ping J; Jing B; Deng G; Jiang Y; Li Y; Tian G; Yu K; Bu Z; Chen H
Biochem Biophys Res Commun; 2008 Jul; 372(2):293-7. PubMed ID: 18501701
[TBL] [Abstract][Full Text] [Related]
11. Prime-boost vaccination with a fowlpox vector and an inactivated avian influenza vaccine is highly immunogenic in Pekin ducks challenged with Asian H5N1 HPAI.
Steensels M; Bublot M; Van Borm S; De Vriese J; Lambrecht B; Richard-Mazet A; Chanavat-Bizzini S; Duboeuf M; Le Gros FX; van den Berg T
Vaccine; 2009 Jan; 27(5):646-54. PubMed ID: 19056442
[TBL] [Abstract][Full Text] [Related]
12. Recombinant fowlpox virus vector-based vaccine completely protects chickens from H5N1 avian influenza virus.
Qiao C; Jiang Y; Tian G; Wang X; Li C; Xin X; Chen H; Yu K
Antiviral Res; 2009 Mar; 81(3):234-8. PubMed ID: 19110002
[TBL] [Abstract][Full Text] [Related]
13. Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions.
Veits J; Römer-Oberdörfer A; Helferich D; Durban M; Suezer Y; Sutter G; Mettenleiter TC
Vaccine; 2008 Mar; 26(13):1688-96. PubMed ID: 18291561
[TBL] [Abstract][Full Text] [Related]
14. Single dose of oil-adjuvanted inactivated vaccine protects chickens from lethal infections of highly pathogenic H5N1 influenza virus.
Hwang SD; Kim HS; Cho SW; Seo SH
Vaccine; 2011 Mar; 29(11):2178-86. PubMed ID: 21172378
[TBL] [Abstract][Full Text] [Related]
15. Generation of reassortant influenza vaccines by reverse genetics that allows utilization of a DIVA (Differentiating Infected from Vaccinated Animals) strategy for the control of avian influenza.
Lee CW; Senne DA; Suarez DL
Vaccine; 2004 Aug; 22(23-24):3175-81. PubMed ID: 15297071
[TBL] [Abstract][Full Text] [Related]
16. In ovo vaccination of chicken embryos with experimental Newcastle disease and avian influenza oil-emulsion vaccines.
Stone H; Mitchell B; Brugh M
Avian Dis; 1997; 41(4):856-63. PubMed ID: 9454919
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the potency, optimal antigen level and lasting immunity of inactivated avian influenza vaccine prepared from H5N1 virus.
Sasaki T; Isoda N; Soda K; Sakamoto R; Saijo K; Hagiwara J; Kokumai N; Ohgitani T; Imamura T; Sawata A; Lin Z; Sakoda Y; Kida H
Jpn J Vet Res; 2009 Feb; 56(4):189-98. PubMed ID: 19358446
[TBL] [Abstract][Full Text] [Related]
18. Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus.
Römer-Oberdörfer A; Veits J; Helferich D; Mettenleiter TC
Vaccine; 2008 May; 26(19):2307-13. PubMed ID: 18395947
[TBL] [Abstract][Full Text] [Related]
19. The adjuvant effect of Sophy β-glucan to the antibody response in poultry immunized by the avian influenza A H5N1 and H5N2 vaccines.
Le T; Le T; Doan TH; Quyen D; Le KX; Pham V; Nagataki M; Nomura H; Ikeue Y; Watanabe Y; Agatsuma T
J Microbiol Biotechnol; 2011 Apr; 21(4):405-11. PubMed ID: 21532325
[TBL] [Abstract][Full Text] [Related]
20. Characterization of avian H5N1 influenza viruses from poultry in Hong Kong.
Shortridge KF; Zhou NN; Guan Y; Gao P; Ito T; Kawaoka Y; Kodihalli S; Krauss S; Markwell D; Murti KG; Norwood M; Senne D; Sims L; Takada A; Webster RG
Virology; 1998 Dec; 252(2):331-42. PubMed ID: 9878612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
